CAMBRIDGE, England--(BUSINESS WIRE)--Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, has expanded its Amperia™ assay portfolio with the ...

Abselion Launches His-tagged Protein Quantification Kit and Sensors for Amperia at PEGS Europe 2025 Ready-to-use solution, developed in collaboration with GenScript, offers rapid and reliable ...

Nomic Publishes Foundational Protein Quantification Technology in Nature Methods The company highlights how its technology powers large-scale proteomic perturbation studies, unveiling Perturb-PBMC, a ...

Abselion establishes US subsidiary at The Engine in Cambridge, MA to support more direct engagement with researchers in North America ...

insights from industryDr. Ruizhi WangFounder and CEOAbselion In this interview, News Medical-Life Sciences speaks with Dr. Ruizhi Wang, Founder and CEO of Abselion, about simplifying the ...

Protein detection sensitivity has historically lagged behind nucleic acid detection by 2-3 orders of magnitude due to the lack of intrinsic signal amplification. While digital methods such as Single ...

A proteomics data pipeline transforms raw mass spectrometry spectra into biologically interpretable protein-level ...

Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, has expanded its Amperia ™ assay portfolio with the launch of its Tagged Protein ...

The last two weeks have been packed with collaborations for unveiling innovative products and kick-starting prosperous partnerships. From quantifying His-tagged proteins and characterizing mutations ...

Proteomics technologies are expanding rapidly due to advances in mass spectrometry, AI-driven analysis, and single-cell approaches. Growing investment and new applications in drug discovery and ...